First Antimicrobial Resistance Benchmark – How will it work?

Semmelweis

To understand better how our forthcoming Antimicrobial Resistance Benchmark was developed and how this tool will be used to track pharmaceutical company action to tackle AMR, Carola Timmel interviews our Executive Director Jayasree K. Iyer.

Follow us and engage with us on LinkedIn and Twitter.